Meeting Details

  • Date: Friday, September 18, 2026
  • Type: 31st Annual General Meeting
  • Location: Conducted through Video Conferencing/Other Audio Visual Means (VC/OAVM)
  • Cut-off Date: September 11, 2026 (for determining voting eligibility)

Proposed Resolutions and Implications

Five resolutions were considered and passed with requisite majority:

1. Ordinary Resolution: Adoption of Standalone Financial Statements for FY ended March 31, 2026, and Reports of Board of Directors and Auditors thereon; and Consolidated Financial Statements for FY ended March 31, 2026, and Report of Auditors thereon

2. Ordinary Resolution: Re-appointment of Mr. Sanjiv Goyal (DIN: 00002841), who retires by rotation

3. Special Resolution: Re-appointment of Dr. Kuldip Kumar Bhasin (DIN: 09250008) as an Independent Director for a second term of five consecutive years

4. Special Resolution: Re-appointment of Dr. Indu Pal Kaur (DIN: 09686862) as an Independent Director for a second term of five consecutive years

5. Ordinary Resolution: Appointment of Dr. Gunmala Suri (DIN: 11879344) as a Non-Executive Non-Independent Director

Voting Process and Methods

  • Remote E-Voting Period: September 15, 2026 (9:00 AM) to September 17, 2026 (5:00 PM)
  • Service Provider: KFin Technologies Limited (RTA of the Company)
  • Insta-Poll Voting: Conducted during the AGM on September 18, 2026 for members present who could not participate in remote e-voting
  • Total Voters: 133 members cast votes through both remote e-voting and insta-poll
  • Scrutinizer: Prince Chadha of P. Chadha & Associates, Company Secretaries

Key Voting Outcomes

Resolution 1 (Ordinary - Financial Statements)

  • Total Votes Polled: 101,660,738 shares (52.332% of outstanding shares)
  • In Favor: 101,646,467 shares (99.986% of votes polled)
  • Against: 14,271 shares (0.014% of votes polled)

Category-wise Breakdown:

  • Promoter & Promoter Group: 100,706,448 shares voted (100% in favor)
  • Public Institutions: 889,678 shares voted (100% in favor)
  • Public Non-Institutions: 64,612 shares voted (77.9128% in favor, 22.0872% against)

Resolution 2 (Ordinary - Reappointment of Sanjiv Goyal)

  • Total Votes Polled: 101,660,738 shares (52.332% of outstanding shares)
  • In Favor: 101,626,376 shares (99.9662% of votes polled)
  • Against: 34,362 shares (0.0338% of votes polled)

Category-wise Breakdown:

  • Promoter & Promoter Group: 100,706,448 shares voted (100% in favor)
  • Public Institutions: 889,678 shares voted (100% in favor)
  • Public Non-Institutions: 64,612 shares voted (46.8179% in favor, 53.1821% against)

Resolution 3 (Special - Reappointment of Kuldip Kumar Bhasin)

  • Total Votes Polled: 101,660,738 shares (52.332% of outstanding shares)
  • In Favor: 101,626,376 shares (99.9662% of votes polled)
  • Against: 34,362 shares (0.0338% of votes polled)

Category-wise Breakdown:

  • Promoter & Promoter Group: 100,706,448 shares voted (100% in favor)
  • Public Institutions: 889,678 shares voted (100% in favor)
  • Public Non-Institutions: 64,612 shares voted (46.8179% in favor, 53.1821% against)

Resolution 4 (Special - Reappointment of Indu Pal Kaur)

  • Total Votes Polled: 101,660,738 shares (52.332% of outstanding shares)
  • In Favor: 101,626,376 shares (99.9662% of votes polled)
  • Against: 34,362 shares (0.0338% of votes polled)

Category-wise Breakdown:

  • Promoter & Promoter Group: 100,706,448 shares voted (100% in favor)
  • Public Institutions: 889,678 shares voted (100% in favor)
  • Public Non-Institutions: 64,612 shares voted (46.8179% in favor, 53.1821% against)

Resolution 5 (Ordinary - Appointment of Gunmala Suri)

  • Total Votes Polled: 101,660,738 shares (52.332% of outstanding shares)
  • In Favor: 101,626,376 shares (99.9662% of votes polled)
  • Against: 34,362 shares (0.0338% of votes polled)

Category-wise Breakdown:

  • Promoter & Promoter Group: 100,706,448 shares voted (100% in favor)
  • Public Institutions: 889,678 shares voted (100% in favor)
  • Public Non-Institutions: 64,612 shares voted (46.8179% in favor, 53.1821% against)

Scrutinizer's Role and Findings

Prince Chadha was appointed as Scrutinizer by the Board of Directors at their meeting held on August 14, 2026. His responsibilities included:

  • Making a Consolidated Scrutinizer's Report of votes cast "in favour" or "against" the resolutions
  • Unblocking e-voting results on September 18, 2026 in the presence of witnesses
  • Maintaining registers received from the service provider both electronically and manually
  • Confirming that 133 members cast votes through remote e-voting and insta-poll

The scrutinizer noted that provisions of Section 188 of the Companies Act regarding non-voting by interested parties were not considered in compiling the report.

Compliance with Laws and Regulations

The voting process complied with:

  • Section 108 and 109 of the Companies Act, 2013 and rules prescribed thereunder
  • SEBI LODR Regulations, 2015
  • MCA General Circular Nos. 14/2020, 17/2020, 20/2020, and 03/2025
  • SEBI Circulars dated May 12, 2020, January 15, 2021, May 13, 2022, January 5, 2023, October 07, 2023, and October 3, 2024
  • SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026

Director Profile Details (Annexure B)

The document includes comprehensive profiles of all directors subject to appointment/reappointment resolutions:

Mr. Sanjiv Goyal (Reappointment):

  • Age: 65 years, Commerce and Law graduate
  • Established Nectar Lifesciences in 1995, Managing Director since inception
  • Total experience: 36 years
  • Shareholding: 47,845,600 equity shares (24.63%) directly + 43,622,400 shares (22.46%) as Karta of Sanjiv (HUF)

Dr. Kuldip Kumar Bhasin (Reappointment - Independent Director):

  • Age: 76 years, Ph.D. in Chemistry from Panjab University
  • Appointment date: September 21, 2026 for 5 years
  • Extensive academic background with 179 research papers and 6 US patents
  • Certified meeting independence criteria under Companies Act and SEBI LODR

Dr. Indu Pal Kaur (Reappointment - Independent Director):

  • Age: 60 years, Ph.D. in Pharmaceutics from Panjab University
  • Appointment date: August 02, 2027 for 5 years
  • 37 years experience in pharmaceutical research and teaching
  • Recipient of National Intellectual Property Award 2021 & 2022 and WIPO Medal for Inventors (2023)
  • Certified meeting independence criteria under Companies Act and SEBI LODR

Dr. Gunmala Suri (Appointment - Non-Executive Non-Independent Director):

  • Professor at University Business School, Panjab University with 27 years experience
  • Ph.D. in Management from Agra University, M.Sc. in Statistics from Gorakhpur University
  • Recipient of multiple awards including Legendary Woman of the Decade (2026)
  • Appointment date: September 18, 2026, liable to retire by rotation

All directors have certified they are not disqualified under the Companies Act or debarred by SEBI order.